Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.
申请公布号
CA2578355(A1)
申请公布日期
2006.03.23
申请号
CA20052578355
申请日期
2005.09.13
申请人
ELIXIR PHARMACEUTICALS, INC.
发明人
HUBER, L., JULIE;HIXON, JEFFREY;MCDONAGH, THOMAS;DISTEFANO, PETER;NAPPER, ANDREW D.;CURTIS, RORY A.;SOLOMON, JONATHAN M.;PONS, JEAN-FRANCOIS;THOMAS, RUSSELL J.
